Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Copy number variation
- Prof. Steve Scherer
-
3. CNVs in human genomes
- Prof. Chris Ponting
-
4. Gene copy number variation in human and primate evolution
- Prof. James Sikela
-
6. CNVs and clinical diagnosis
- Dr. Brynn Levy
-
7. Quantitative CNV testing in molecular diagnostics
- Prof. Dimitri J. Stavropoulos
-
8. Mendelian CNV mutations
- Prof. Joris Vermeesch
-
9. Copy number variation in neuropsychiatric disorders
- Dr. Christian Marshall
-
10. Copy number variation in association studies of human disease
- Dr. Steven McCarroll
-
11. Ethical considerations in dealing with CNV information
- Dr. Holly Tabor
- Archived Lectures *These may not cover the latest advances in the field
-
15. Population genetics of structural variation
- Dr. Don Conrad
-
16. Databases for CNV in control and disease populations
- Dr. Lars Feuk
-
17. Copy number variation in mental retardation
- Dr. Joris Veltman
-
19. Structural variants and susceptibility to common human disorders
- Prof. Xavier Estivill
-
20. Indels, CNVs and the spectrum of human genome variation
- Prof. Samuel Levy
-
21. Genome structure and expression
- Prof. Alexandre Reymond
-
22. Quantitative CNV testing in molecular diagnostics
- Prof. Martin Somerville
Printable Handouts
Navigable Slide Index
- Introduction
- Why focus on CNVs?
- Outline
- Existing guidelines on returning results
- Should results be returned?
- The NBAC report, 1999
- Johnston and Kaye (2004) paper - UK Biobank
- NIH GWAS points to consider
- NHLBI working group 2006
- Shalowitz and Miller
- Ravitsky and Wilfond
- Consensus and discussion
- Returning CNV results
- What about CNVs?
- Arguments for returning CNV results
- Rights of participant / ownership of data
- Clinical significance
- Reciprocity
- Research imperative
- Arguments against returning CNV results
- Results are research only
- Results don't have clinical significance
- Phenotypic and genotypic heterogeneity
- Avoiding CNV exceptionalism
- Case study 1A: what results mean to families
- Case study 1B: what results mean to families
- Case study 2: clinical utility
- Case study 3: right to know?
- What we still need to know
- Recommendations
- Acknowledgements
- References (1)
- References (2)
Topics Covered
- Why focus on CNVs?
- Existing guidelines on returning results
- National Bioethics Advisory Commission
- UK Biobank
- NIH guidelines
- Arguments FOR returning CNV results
- Arguments AGAINST returning CNV results
- Avoiding CNV exceptionalism
- What results mean to families
- What we still need to know
Talk Citation
Tabor, H. (2010, February 25). Ethical considerations in dealing with CNV information [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/RUNK3066.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Holly Tabor has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.